TABLE 1.
Strain or plasmid | MLST | GenBank accession no. (SRA accession no.) |
No. of reads (fold coverage) |
Size (bp) | % GC content |
AMR phenotype | Inc type | Resistance gene(s)b | Isolation yr |
---|---|---|---|---|---|---|---|---|---|
USMARC-69807c | ST10 |
CP032379
(SRR8063632) |
75,195 (150×) | 4,844,213 | 52.2 | AmApFT (Ax)CSSuTe |
aac(6′)-laad | 2006e | |
pSD1-69807 | CP032380 | 1,058 (74×) | 96,567 | 52.8 | IncA/C2 |
blaCMY-2, sul2, blaTEM-81, floR, aph(3′′)-lb, aph(6)-ld, tet(C) |
|||
pSD2-69807 | CP032381 | 893 (66×) | 74,562 | 48.6 | IncX/IncFII | vga(C) | |||
USMARC-69838c ,f | ST10 |
CP032449
(SRR8064828) |
71,397 (150×) | 4,913,018 | 52.2 | AmApFTAxKCSSuTe |
blaCMY-2, blaCMY-2, sul2, blaTEM-81, aph(6)-ld, aph(3′′)-lb, aph(3′)-la, aac(6′)-laad , floR, tet(C) |
2012g | |
pSD1-69838 | CP032450 | 3,196 (195×) | 114,923 | 49.5 | IncA/C2; IncX/IncFII |
vga(C) | |||
USMARC-69840c | ST10 |
CP032446
(SRR8034318) |
83,212 (176×) | 4,844,133 | 52.2 | CKNaSSuTe | aac(6′)-laad | 2012g | |
pSD1-69840 | CP032447 | 1,275 (106×) | 74,560 | 48.6 | IncX; IncFII(s) | vga(C) | |||
pSD2-69840 | CP032448 | 652 (70×) | 77,171 | 53.4 | IncA/C2 |
floR, aph(6)-ld, aph(3′′)-lb, aph(3′)-la, sul2, tet(C) |
ST, sequence type; AMR, antimicrobial resistance; Am, amoxicillin-clavulanic acid; Ap, ampicillin; F, cefoxitin; Ax, ceftriaxone; C, chloramphenicol; K, kanamycin; S, streptomycin; Su, sulfisoxazole; Sxt, sulfamethoxazole-trimethoprim; T, ceftiofur; Te, tetracycline; (), indicates intermediate resistance.
Resistance genes were identified using the Comprehensive Antibiotic Resistance Database (version 2.0.3) Resistance Gene Identifier (version 4.2.0) (13).
Salmonella enterica subsp. enterica serovar Dublin strain.
May be phenotypically silent (cryptic) and not generally noted as conferring aminoglycoside resistance (14).
Source: pre-evisceration carcass.
Two copies of blaCMY-2 present, DZA56_07580 and DZA56_07860.
Source: subiliac lymph node.